Literature DB >> 18182392

Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors.

Julie Perroy1, Fabrice Raynaud, Vincent Homburger, Marie-Claude Rousset, Ludovic Telley, Joël Bockaert, Laurent Fagni.   

Abstract

Functional interplay between ionotropic and metabotropic receptors frequently involves complex intracellular signaling cascades. The group I metabotropic glutamate receptor mGlu5a co-clusters with the ionotropic N-methyl-d-aspartate (NMDA) receptor in hippocampal neurons. In this study, we report that a more direct cross-talk can exist between these types of receptors. Using bioluminescence resonance energy transfer in living HEK293 cells, we demonstrate that mGlu5a and NMDA receptor clustering reflects the existence of direct physical interactions. Consequently, the mGlu5a receptor decreased NMDA receptor current, and reciprocally, the NMDA receptor strongly reduced the ability of the mGlu5a receptor to release intracellular calcium. We show that deletion of the C terminus of the mGlu5a receptor abolished both its interaction with the NMDA receptor and reciprocal inhibition of the receptors. This direct functional interaction implies a higher degree of target-effector specificity, timing, and subcellular localization of signaling than could ever be predicted with complex signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182392     DOI: 10.1074/jbc.M705661200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Metabotropic glutamate receptor 5 mediates phosphorylation of vascular endothelial cadherin and nuclear localization of β-catenin in response to homocysteine.

Authors:  Richard S Beard; Jason J Reynolds; Shawn E Bearden
Journal:  Vascul Pharmacol       Date:  2012-01-21       Impact factor: 5.773

2.  Type 1 metabotropic glutamate receptors (mGlu1) trigger the gating of GluD2 delta glutamate receptors.

Authors:  Visou Ady; Julie Perroy; Ludovic Tricoire; Claire Piochon; Selma Dadak; Xiaoru Chen; Isabelle Dusart; Laurent Fagni; Bertrand Lambolez; Carole Levenes
Journal:  EMBO Rep       Date:  2013-12-15       Impact factor: 8.807

Review 3.  Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert.

Authors:  Andreas Reiner; Joshua Levitz
Journal:  Neuron       Date:  2018-06-27       Impact factor: 17.173

4.  The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control.

Authors:  María Rodríguez-Muñoz; Pilar Sánchez-Blázquez; Ana Vicente-Sánchez; Esther Berrocoso; Javier Garzón
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

5.  Posttranslational modification impact on the mechanism by which amyloid-β induces synaptic dysfunction.

Authors:  Katarzyna M Grochowska; PingAn Yuanxiang; Julia Bär; Rajeev Raman; Gemma Brugal; Giriraj Sahu; Michaela Schweizer; Arthur Bikbaev; Stephan Schilling; Hans-Ulrich Demuth; Michael R Kreutz
Journal:  EMBO Rep       Date:  2017-04-18       Impact factor: 8.807

6.  Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators.

Authors:  Chrysa Malosh; Mark Turlington; Thomas M Bridges; Jerri M Rook; Meredith J Noetzel; Paige N Vinson; Thomas Steckler; Hilde Lavreysen; Claire Mackie; José M Bartolomé-Nebreda; Susana Conde-Ceide; Carlos M Martínez-Viturro; María Piedrafita; M Rosa Sánchez-Casado; Gregor J Macdonald; J Scott Daniels; Carrie K Jones; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Shaun R Stauffer
Journal:  Bioorg Med Chem Lett       Date:  2015-10-09       Impact factor: 2.823

7.  Targeting putative mu opioid/metabotropic glutamate receptor-5 heteromers produces potent antinociception in a chronic murine bone cancer model.

Authors:  Branden A Smeester; Mary M Lunzer; Eyup Akgün; Alvin J Beitz; Philip S Portoghese
Journal:  Eur J Pharmacol       Date:  2014-09-17       Impact factor: 4.432

8.  Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors.

Authors:  Alessia Luoni; Peter Gass; Paolo Brambilla; Mirella Ruggeri; Marco A Riva; Dragos Inta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-08-31       Impact factor: 5.270

9.  Studies of the metabotropic glutamate receptor 5 radioligand [¹¹C]ABP688 with N-acetylcysteine challenge in rhesus monkeys.

Authors:  Christine M Sandiego; Nabeel Nabulsi; Shu-Fei Lin; David Labaree; Soheila Najafzadeh; Yiyun Huang; Kelly Cosgrove; Richard E Carson
Journal:  Synapse       Date:  2013-03-27       Impact factor: 2.562

10.  Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling.

Authors:  Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Javier Garzón
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.